Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2017 · 10-Q
Revenue$77.21M$77.21M+12.6% vs Q3 2016 Net Income$6.69M$6.69M+10.2% vs Q3 2016 EPS Diluted$0.55$0.55+7.8% vs Q3 2016 Gross Profit$58,183,000+11.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$12,505,000+80.2% Free Cash Flowderived$11,146,000+97.1% Margins · derivedGross margin75.4%−0.7 pt vs Q3 2016
Operating margin13.2%+0.2 pt vs Q3 2016
Net margin8.7%−0.2 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 8, 2017 · 39 d after period end